The Alliance For Benzodiazepine Best Practices
EIN: 824973519 · Portland, OR · NTEE: H05
| Metric | Value |
|---|---|
| Total Revenue | $167K |
| Total Expenses | $78K |
| Net Assets | $50K |
Is The Alliance For Benzodiazepine Best Practices Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About The Alliance For Benzodiazepine Best Practices
The Alliance For Benzodiazepine Best Practices (EIN: 824973519) is a nonprofit organization based in Portland, OR, classified under NTEE code H05. The organization reported total revenue of $167K and total assets of $97K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of The Alliance For Benzodiazepine Best Practices's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
The Alliance For Benzodiazepine Best Practices is a small nonprofit that has been operating for 6 years, with 3 years of IRS 990 filings on record (2019–2023). Revenue has grown at a compound annual rate of -12.1%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $109K |
| Total Expenses | $78K |
| Surplus / Deficit | +$32K |
| Total Assets | $62K |
| Total Liabilities | $12K |
| Net Assets | $50K |
| Operating Margin | 29.1% |
| Debt-to-Asset Ratio | 19.4% |
| Months of Reserves | 9.6 months |
Financial Health Grade: A
In 2023, The Alliance For Benzodiazepine Best Practices reported a surplus of $32K with revenue exceeding expenses, holds 9.6 months of operating reserves (strong position), has a debt-to-asset ratio of 19.4% (very low leverage).
Financial Trends
Over 3 years of filings (2019–2023), The Alliance For Benzodiazepine Best Practices's revenue has declined at a compound annual growth rate (CAGR) of -12.1%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -60.0% | -64.3% | +9.3% |
| 2020 | +49.3% | -0.9% | +391.7% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2020 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for The Alliance For Benzodiazepine Best Practices has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates The Alliance For Benzodiazepine Best Practices with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $32K, with revenue exceeding expenses.
- Debt-to-asset ratio: 19.4%.
Frequently Asked Questions about The Alliance For Benzodiazepine Best Practices
Is The Alliance For Benzodiazepine Best Practices a legitimate charity?
The Alliance For Benzodiazepine Best Practices (EIN: 824973519) is a registered tax-exempt nonprofit based in Oregon. It has 3 years of IRS 990 filings on record. Total revenue: $167K. No red flags identified. Financial health grade: A.
How does The Alliance For Benzodiazepine Best Practices spend its money?
The Alliance For Benzodiazepine Best Practices reported $167K in total revenue in IRS 990 filings. 3 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to The Alliance For Benzodiazepine Best Practices tax-deductible?
The Alliance For Benzodiazepine Best Practices is registered as a tax-exempt nonprofit (EIN: 824973519). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is The Alliance For Benzodiazepine Best Practices located?
The Alliance For Benzodiazepine Best Practices is headquartered in Portland, Oregon and files with the IRS under EIN 824973519. It is classified under NTEE code H05.
How many years of IRS 990 filings does The Alliance For Benzodiazepine Best Practices have?
The Alliance For Benzodiazepine Best Practices has 3 years of IRS 990 filings on record at NonprofitSpending. Additional filing years may become available as the IRS releases new data. The most recent filing shows $167K in total revenue.
Filing History
IRS 990 filing history for The Alliance For Benzodiazepine Best Practices showing financial trends over 3 years of public records:
Over 3 years of IRS 990 filings (2019–2023), The Alliance For Benzodiazepine Best Practices's revenue has declined by 40.3%, moving from $183K to $109K. Total assets increased by 437.4% over the same period, from $11K to $62K. Total functional expenses fell by 64.6%, from $219K to $78K. In its most recent filing year (2023), The Alliance For Benzodiazepine Best Practices reported a surplus of $32K, with revenue exceeding expenses. The organization holds $12K in liabilities against $62K in assets (debt-to-asset ratio: 19.4%), resulting in net assets of $50K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $109K | $78K | $62K | $12K | — | — |
| 2020 | $273K | $217K | $57K | $1 | — | View 990 |
| 2019 | $183K | $219K | $11K | $11K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $109K, expenses of $78K, and assets of $62K (revenue -60.0% year-over-year).
- 2020: Revenue of $273K, expenses of $217K, and assets of $57K (revenue +49.3% year-over-year).
- 2019: Revenue of $183K, expenses of $219K, and assets of $11K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for The Alliance For Benzodiazepine Best Practices:
Data Sources and Methodology
This transparency report for The Alliance For Benzodiazepine Best Practices is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.